Skip to main content

Table 1 Patient demographics at baseline for the mild AD dementia patient population (N = 200) in the UK GERAS study [6]

From: Potential cost savings to be made by slowing cognitive decline in mild Alzheimer’s disease dementia using a model derived from the UK GERAS observational study

Characteristic

 

Mean age in years [SD]

78.9 [6.7]

Gender, n female [%]

100 [50]

MMSE score, mean [SD]

23.1 [1.6]

Mean time since diagnosis in years [SD]

1.8 [2.1]

Caregiver is spouse, n [%]

144 [72.0]

AD medication use

 

 No AD medication, n [%]

31 [15.5]

 Acetylcholinesterase inhibitor use, n [%]

167 [83.5]

 Memantine use, n [%]

1 [0.5]

 Acetylcholinesterase inhibitor + memantine, n [%]

1 [0.5]

  1. SD standard deviation, AD Alzheimer’s disease